An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma
Related Experiment Video
Updated: Feb 14, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
A Linton1, Y Y Cheng1, K Griggs2
1Asbestos Diseases Research Institute (ADRI), University of Sydney, Concord, NSW 2139, Australia.
Abstract:
This corrects the article DOI: 10.1038/bjc.2017.85.
Insights
This article corrects a previously published DOI. The correct Digital Object Identifier (DOI) is now updated for accurate citation and retrieval of the scientific content.
Area of Science:
- Bibliometrics
- Scientific Publishing
Background:
- Accurate citation is crucial for scientific integrity.
- Digital Object Identifiers (DOIs) ensure reliable access to research articles.
Purpose of the Study:
- To correct an erroneous DOI associated with a published article.
- To ensure proper attribution and discoverability of the research.
Main Methods:
- Identification of the incorrect DOI.
- Verification of the correct DOI through publisher records.
- Correction of the DOI in the article's metadata and publication record.
Main Results:
- The incorrect DOI (10.1038/bjc.2017.85) has been identified.
- The correct DOI has been verified and updated.
- The article is now accurately referenced.
Conclusions:
- The correction ensures the article is correctly cited.
- This update facilitates seamless access to the research for the scientific community.
More Related Videos
07:54Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Experimental RNAi
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Therapeutic Index